Update on a Quality Initiative to Standardize Perioperative Care for Continuous Subcutaneous Insulin Infusion Therapy

Patricia A. Mackey, Bithika M. Thompson, Mary E. Boyle, Heidi A. Apsey, Karen M. Seifert, Richard T. Schlinkert, Joshua D. Stearns, Curtiss B. Cook

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

OBJECTIVE: The objective of the analysis was to review the effectiveness of a care process model (CPM) developed to guide management of patients on insulin pump therapy undergoing elective surgical procedures.

METHODS: Electronic medical records were reviewed to assess the impact of the CPM on documentation of insulin pump status, glucose monitoring, and safety during the perioperative phase of care. Post-CPM care was compared with management provided before CPM implementation.

RESULTS: We reviewed 45 cases on insulin pump therapy in the pre-CPM cohort and 106 in the post-CPM cohort. Demographic characteristics, categories of surgery, and perioperative times were not significantly different between the 2 groups. Recommended hemoglobin A1c monitoring occurred in 73% of cases in the pre-CPM cohort but improved to 94% in the post-CPM group (P < .01). There was a higher frequency of documentation of the insulin pump during the preoperative, intraoperative, and postanesthesia care unit segments of care in the post- vs pre-CPM periods (all P < .01). The number of cases with intraoperative glucose monitoring increased (57% pre-CPM vs 81% post-CPM; P < .01). Glycemic control was comparable between the 2 CPM periods. Hypoglycemia was rare, with only 3 episodes in the pre-CPM group and 4 in the post-CPM. No adverse events associated with perioperative insulin pump use were observed.

CONCLUSIONS: This analysis adds to previous data on use of insulin pump therapy during the perioperative period. Some processes require additional attention, but data continue to indicate that a standardized approach to care can lead to a successful and safe transition of insulin pump therapy throughout the perioperative period.

Original languageEnglish (US)
Pages (from-to)1299-1306
Number of pages8
JournalJournal of diabetes science and technology
Volume9
Issue number6
DOIs
StatePublished - Jun 19 2015

Fingerprint

Perioperative Care
Subcutaneous Infusions
Insulin
Pumps
Perioperative Period
Group Processes
Documentation
Therapeutics
Intraoperative Care
Elective Surgical Procedures
Intraoperative Monitoring
Glucose
Electronic Health Records
Hypoglycemia
Monitoring
Hemoglobins
Demography
Electronic medical equipment
Safety
Hemoglobin

Keywords

  • CSII
  • diabetes mellitus
  • insulin pump
  • perioperative
  • surgery

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Bioengineering
  • Medicine(all)
  • Biomedical Engineering

Cite this

Mackey, P. A., Thompson, B. M., Boyle, M. E., Apsey, H. A., Seifert, K. M., Schlinkert, R. T., ... Cook, C. B. (2015). Update on a Quality Initiative to Standardize Perioperative Care for Continuous Subcutaneous Insulin Infusion Therapy. Journal of diabetes science and technology, 9(6), 1299-1306. https://doi.org/10.1177/1932296815592027

Update on a Quality Initiative to Standardize Perioperative Care for Continuous Subcutaneous Insulin Infusion Therapy. / Mackey, Patricia A.; Thompson, Bithika M.; Boyle, Mary E.; Apsey, Heidi A.; Seifert, Karen M.; Schlinkert, Richard T.; Stearns, Joshua D.; Cook, Curtiss B.

In: Journal of diabetes science and technology, Vol. 9, No. 6, 19.06.2015, p. 1299-1306.

Research output: Contribution to journalArticle

Mackey, PA, Thompson, BM, Boyle, ME, Apsey, HA, Seifert, KM, Schlinkert, RT, Stearns, JD & Cook, CB 2015, 'Update on a Quality Initiative to Standardize Perioperative Care for Continuous Subcutaneous Insulin Infusion Therapy', Journal of diabetes science and technology, vol. 9, no. 6, pp. 1299-1306. https://doi.org/10.1177/1932296815592027
Mackey, Patricia A. ; Thompson, Bithika M. ; Boyle, Mary E. ; Apsey, Heidi A. ; Seifert, Karen M. ; Schlinkert, Richard T. ; Stearns, Joshua D. ; Cook, Curtiss B. / Update on a Quality Initiative to Standardize Perioperative Care for Continuous Subcutaneous Insulin Infusion Therapy. In: Journal of diabetes science and technology. 2015 ; Vol. 9, No. 6. pp. 1299-1306.
@article{fd62968bf3c944beb4aac0c1426bdef2,
title = "Update on a Quality Initiative to Standardize Perioperative Care for Continuous Subcutaneous Insulin Infusion Therapy",
abstract = "OBJECTIVE: The objective of the analysis was to review the effectiveness of a care process model (CPM) developed to guide management of patients on insulin pump therapy undergoing elective surgical procedures.METHODS: Electronic medical records were reviewed to assess the impact of the CPM on documentation of insulin pump status, glucose monitoring, and safety during the perioperative phase of care. Post-CPM care was compared with management provided before CPM implementation.RESULTS: We reviewed 45 cases on insulin pump therapy in the pre-CPM cohort and 106 in the post-CPM cohort. Demographic characteristics, categories of surgery, and perioperative times were not significantly different between the 2 groups. Recommended hemoglobin A1c monitoring occurred in 73{\%} of cases in the pre-CPM cohort but improved to 94{\%} in the post-CPM group (P < .01). There was a higher frequency of documentation of the insulin pump during the preoperative, intraoperative, and postanesthesia care unit segments of care in the post- vs pre-CPM periods (all P < .01). The number of cases with intraoperative glucose monitoring increased (57{\%} pre-CPM vs 81{\%} post-CPM; P < .01). Glycemic control was comparable between the 2 CPM periods. Hypoglycemia was rare, with only 3 episodes in the pre-CPM group and 4 in the post-CPM. No adverse events associated with perioperative insulin pump use were observed.CONCLUSIONS: This analysis adds to previous data on use of insulin pump therapy during the perioperative period. Some processes require additional attention, but data continue to indicate that a standardized approach to care can lead to a successful and safe transition of insulin pump therapy throughout the perioperative period.",
keywords = "CSII, diabetes mellitus, insulin pump, perioperative, surgery",
author = "Mackey, {Patricia A.} and Thompson, {Bithika M.} and Boyle, {Mary E.} and Apsey, {Heidi A.} and Seifert, {Karen M.} and Schlinkert, {Richard T.} and Stearns, {Joshua D.} and Cook, {Curtiss B.}",
year = "2015",
month = "6",
day = "19",
doi = "10.1177/1932296815592027",
language = "English (US)",
volume = "9",
pages = "1299--1306",
journal = "Journal of diabetes science and technology",
issn = "1932-2968",
publisher = "Diabetes Technology Society",
number = "6",

}

TY - JOUR

T1 - Update on a Quality Initiative to Standardize Perioperative Care for Continuous Subcutaneous Insulin Infusion Therapy

AU - Mackey, Patricia A.

AU - Thompson, Bithika M.

AU - Boyle, Mary E.

AU - Apsey, Heidi A.

AU - Seifert, Karen M.

AU - Schlinkert, Richard T.

AU - Stearns, Joshua D.

AU - Cook, Curtiss B.

PY - 2015/6/19

Y1 - 2015/6/19

N2 - OBJECTIVE: The objective of the analysis was to review the effectiveness of a care process model (CPM) developed to guide management of patients on insulin pump therapy undergoing elective surgical procedures.METHODS: Electronic medical records were reviewed to assess the impact of the CPM on documentation of insulin pump status, glucose monitoring, and safety during the perioperative phase of care. Post-CPM care was compared with management provided before CPM implementation.RESULTS: We reviewed 45 cases on insulin pump therapy in the pre-CPM cohort and 106 in the post-CPM cohort. Demographic characteristics, categories of surgery, and perioperative times were not significantly different between the 2 groups. Recommended hemoglobin A1c monitoring occurred in 73% of cases in the pre-CPM cohort but improved to 94% in the post-CPM group (P < .01). There was a higher frequency of documentation of the insulin pump during the preoperative, intraoperative, and postanesthesia care unit segments of care in the post- vs pre-CPM periods (all P < .01). The number of cases with intraoperative glucose monitoring increased (57% pre-CPM vs 81% post-CPM; P < .01). Glycemic control was comparable between the 2 CPM periods. Hypoglycemia was rare, with only 3 episodes in the pre-CPM group and 4 in the post-CPM. No adverse events associated with perioperative insulin pump use were observed.CONCLUSIONS: This analysis adds to previous data on use of insulin pump therapy during the perioperative period. Some processes require additional attention, but data continue to indicate that a standardized approach to care can lead to a successful and safe transition of insulin pump therapy throughout the perioperative period.

AB - OBJECTIVE: The objective of the analysis was to review the effectiveness of a care process model (CPM) developed to guide management of patients on insulin pump therapy undergoing elective surgical procedures.METHODS: Electronic medical records were reviewed to assess the impact of the CPM on documentation of insulin pump status, glucose monitoring, and safety during the perioperative phase of care. Post-CPM care was compared with management provided before CPM implementation.RESULTS: We reviewed 45 cases on insulin pump therapy in the pre-CPM cohort and 106 in the post-CPM cohort. Demographic characteristics, categories of surgery, and perioperative times were not significantly different between the 2 groups. Recommended hemoglobin A1c monitoring occurred in 73% of cases in the pre-CPM cohort but improved to 94% in the post-CPM group (P < .01). There was a higher frequency of documentation of the insulin pump during the preoperative, intraoperative, and postanesthesia care unit segments of care in the post- vs pre-CPM periods (all P < .01). The number of cases with intraoperative glucose monitoring increased (57% pre-CPM vs 81% post-CPM; P < .01). Glycemic control was comparable between the 2 CPM periods. Hypoglycemia was rare, with only 3 episodes in the pre-CPM group and 4 in the post-CPM. No adverse events associated with perioperative insulin pump use were observed.CONCLUSIONS: This analysis adds to previous data on use of insulin pump therapy during the perioperative period. Some processes require additional attention, but data continue to indicate that a standardized approach to care can lead to a successful and safe transition of insulin pump therapy throughout the perioperative period.

KW - CSII

KW - diabetes mellitus

KW - insulin pump

KW - perioperative

KW - surgery

UR - http://www.scopus.com/inward/record.url?scp=85018195803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018195803&partnerID=8YFLogxK

U2 - 10.1177/1932296815592027

DO - 10.1177/1932296815592027

M3 - Article

C2 - 26092687

AN - SCOPUS:85018195803

VL - 9

SP - 1299

EP - 1306

JO - Journal of diabetes science and technology

JF - Journal of diabetes science and technology

SN - 1932-2968

IS - 6

ER -